John W. Martin
Corporate Officer/Principal at The European Commission
Profile
John W.
Martin was the founder of Ark Therapeutics Group Plc, which was founded in 1997, where he held the title of Chief Scientific Officer from 1997 to 2010.
Currently, he is the Chairman of Cardiovascular Medicine at University College London and the Chairman of the Expert Cardiovascular Committee at The European Commission.
In the past, he held the position of Member of the Animal Procedures Committee at the United Kingdom Ministry of Home Affairs from 1998 to 2006, Head of Pharmacology & Cardiovascular Research at Wellcome Research Laboratories from 1986 to 1996, and Vice President at The European Society of Cardiology in 2002.
John W. Martin active positions
| Companies | Position | Start |
|---|---|---|
| The European Commission | Corporate Officer/Principal | 2010-11-24 |
| University College London | Corporate Officer/Principal | - |
Former positions of John W. Martin
| Companies | Position | End |
|---|---|---|
| United Kingdom Ministry of Home Affairs | Corporate Officer/Principal | 2005-12-31 |
| The European Society of Cardiology | Corporate Officer/Principal | 2001-12-31 |
| Wellcome Research Laboratories | Chief Tech/Sci/R&D Officer | 1995-12-31 |
Ark Therapeutics Group Plc
 Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Commercial Services |
| Wellcome Research Laboratories | |
| The European Society of Cardiology | |
| United Kingdom Ministry of Home Affairs | Government |
| The European Commission | Government |
- Stock Market
- Insiders
- John W. Martin
